CASP3 and breast carcinoma: Our results showed a dose dependent increase in caspase activity in PC3 cells with an increase in the concentration of CoCl2·6H2O. Similar results were observed in ruthenium polypyridyl complexes, which lead to increased caspase-3 activity in breast cancer cells (Cao et al. 2015).